Use Of Itolizumab On Moderate To Severe COVID-19 Patients
Biotech major Biocon has announced that it is launching a new biological drug Itolizumab to treat moderate to severe cases of COVID-19. The company received approval from the Drug Controllers General of India to market the injection for emergency use in India for treatment of cytokine release syndrome in moderate/severe cases of ARDS caused due to coronavirus.
Related Bookmarks
- Scottsdale Arizona Fitness Personal Trainer for Seniors
- Clinique Privée
- Botox Montreal
- Advantage of Hypnotherapy over Surgery for Weight Loss
- Tender Dental Care
- Visit leading center to get assistance for Self-Hypnosis for Anxiety
- Teeth Whitening Strips: Things to Know
- VISIT RENOWNED ONLINE STORE TO BUY THE BEST BRAND OF RAW HONEY
- Why To Settle On Teeth Whitening Strips
- Why One Should Focus On Their Teeth Whitening Routine?
Recent Profiles
Skyward Wings
Carmella Morrison, Hudson Valley Team
Leonid Nikolaev
188bet - San Choi Ca Cuoc Uy Tin Hang Dau
Rutvik Soni
Urbanbus
Sun20wintech
Critter Removal
Melissap
Institute8xbet